Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in ...
In July 2025, the White House released America’s AI Action Plan, a sweeping policy framework asserting that “the United States is in a race to achieve global dominance in artificial intelligence,” and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback